ERBB2 and breast carcinoma: One example that might illustrate this idea is the case of breast cancer (BC), in which initial molecular profiling was restricted to the expression of certain proteomic markers involved in BC pathogenesis like estrogen receptors, progesterone receptors, and the upregulation of HER2/ERBB2 (16, 17).